A detailed history of Creative Financial Designs Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Creative Financial Designs Inc holds 15,000 shares of LUCD stock, worth $16,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Previous 8,500 76.47%
Holding current value
$16,200
Previous $9,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$0.97 - $1.48 $6,305 - $9,620
6,500 Added 76.47%
15,000 $15,000
Q2 2025

Aug 04, 2025

BUY
$1.09 - $1.65 $9,265 - $14,025
8,500 New
8,500 $9,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $41.7M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.